Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Multinational Pharmaceutical Firms' FDI in China

Multinational Pharmaceutical Firms' FDI in China

Jiang, Fuming

Paperback

Business General

ISBN10: 3639100395
ISBN13: 9783639100396
Publisher: Blues Kids Of Amer
Published: Nov 10 2008
Pages: 492
Weight: 1.44
Height: 0.99 Width: 6.00 Depth: 9.00
Language: English
The opening-up of Chinese economy in 1978 and the subsequent reforms provided multinational corporations with tremendous opportunities to invest in and explore the world's largest developing market. China, however, presents a complicated and difficult operating business environment for foreign investors. This PhD thesis demon-strates a comprehensive, multi-level study on 44 multinational pharmaceutical firms' strategic planning and implementation of foreign direct investment (FDI) strategies in China during the first tweenty years of China's open-door policy and economic reform era. The study developed an integrated master conceptual framework and examined a series of key issues related to the strategic FDI decision-making and implementation processes, including FDI determinants, entry mode choice between joint venture and wholly owned subsidiary, joint venture partners selection, FDI operating location choice within China, and the determinants of FDI effectiveness and success in China. The thesis received exemplary reports from all examiners, and the PhD candidate was awarded the Research Achievement Prize by Swinburne University.

Also in

Business General

View All